A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M. Langley, Ilse Dieussaert, Jean‐François Toussaint et al.|The Journal of Infectious Diseases|2016Cited by 67
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized TrialXavier Sáez‐Llorens, Nicolas Vanhoutte, Ximena Norero et al.|The Journal of Infectious Diseases|2023Cited by 13
ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calvesRineke de Jong, Ann‐Muriel Steff, Norbert Stockhofe-Zurwieden et al.|Nature Communications|2022Cited by 11
Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein–Based VaccinePeyman Banooni, Marta Picciolato, Ouzama Henry et al.|Clinical Infectious Diseases|2025Cited by 7
ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calvesRineke de Jong, Ann‐Muriel Steff, Norbert Stockhofe-Zurwieden et al.|Research Square|2021Cited by 5